Recall Ledger

Levothyroxine Sodium Tablets recall (ACCORD HEALTHCARE, INC.)

DrugClass IIOngoing

Summary: ACCORD HEALTHCARE, INC. is recalling Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-450-17.. Reason: Subpotent Drug.

What is being recalled

Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-450-17.

Why

Subpotent Drug

How serious is it

Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.

Where it was sold

Nationwide within the United States

How to tell if yours is affected

Lot #: D2401813, D2401814, Exp. Date 08/31/2026; D2500200, D2500219, Exp. Date 12/31/2026.

What to do

Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.

Recall facts

Recall numberD-0778-2026
CategoryDrug
AgencyU.S. Food and Drug Administration (FDA)
SeverityClass II
StatusOngoing
Recall startedAugust 6, 2026
ReportedSeptember 2, 2026
CompanyACCORD HEALTHCARE, INC.
Company locationRaleigh, NC, United States
Initiated byVoluntary: Firm initiated
QuantityN/A

More recalls from ACCORD HEALTHCARE, INC. · all drug recalls · recalls from August 2026

Official FDA record